Jane Abbott1, Sumita Verma2, Sushma Saksena3

  • 1Gastroenterology Registrar, Department of Hepatology, Royal London Hospital, Barts Health NHS Trust; Department of Immunobiology, Blizard Institute, Queen Mary University of London.

概括

医疗保健专业人员愿意考虑长期腹部排水 (LTAD) 治疗末期肝病 (ESLD) . 然而,感知到的感染风险和社区管理挑战阻碍了采用,促使进一步研究.